Filter Results
:
(2,803)
Show Results For
-
All HBS Web
(9,894)
- Faculty Publications (2,803)
Show Results For
-
All HBS Web
(9,894)
- Faculty Publications (2,803)
Page 1 of
2,803
Results
→
- January 2023
- Supplement
Mellody Hobson at Ariel Investments
By: Lakshmi Ramarajan and Francesca Gino
Ramarajan, Lakshmi, and Francesca Gino. "Mellody Hobson at Ariel Investments." Harvard Business School Multimedia/Video Supplement 423-719, January 2023.
- January 2023
- Case
Zaoui & Co. (A): Consigliere for High Stakes M&A Transactions
By: Ashish Nanda, Alex Kitsberg and Zack Kurtovich
In September 2019, Zaoui & Co.’s close-knit team of professionals convened for their annual off-site. In its nine years of operation, the boutique investment bank founded by the brothers Michael (HBS ’83) and Yoel Zaoui (Stanford GSB ’88), had garnered a track record...
View Details
- January 2023
- Supplement
Zaoui & Co. (B): Executing the Odyssey SPAC Transaction
By: Ashish Nanda, Alex Kitsberg and Zack Kurtovich
In September 2019, founding partners Michael and Yoel Zaoui decided to add principal investing to Zaoui & Co.’s offerings. The case outlines how, over the next two years, Zaoui & Co. pursued the formation of a SPAC, Odyssey Acquisitions, followed by the identification...
View Details
- January 2023
- Teaching Note
Mellody Hobson at Ariel Investments
By: Lakshmi Ramarajan and Rachel Tropp
- January 2023
- Teaching Note
The Opioid Settlement and Executive Pay at AmerisourceBergen
By: Suraj Srinivasan and Li-Kuan Ni
Teaching Note for HBS Case No 122-014. In 2020, AmerisourceBergen Corporation, a Fortune 50 company in the drug distribution industry, agreed to settle thousands of lawsuits filed nationwide against the company for its opioid distribution practices that critics alleged...
View Details
Keywords:
Opioids;
Shareholder Activism;
Investment Activism;
Corporate Accountability;
Corporate Governance;
Governance Compliance;
Governance Controls;
Executive Compensation;
Risk Management;
Corporate Social Responsibility and Impact;
Business and Shareholder Relations;
Business and Stakeholder Relations;
Distribution Industry;
Health Industry;
Pharmaceutical Industry;
United States;
West Virginia;
Tennessee;
Ohio;
Pennsylvania
- January 2023
- Supplement
The END Fund (B)
By: V. Kasturi Rangan and Courtney Han
Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the...
View Details
- January 2023
- Case
The END Fund: To Eliminate Neglected Tropical Diseases
By: V. Kasturi Rangan and Courtney Han
Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the...
View Details
- 2023
- Working Paper
Summarizing the Mental Customer Journey
By: Julian De Freitas, Ahmet Uğuralp, Zeliha Uğuralp, Pechthida Kim and Tomer Ullman
How do consumers summarize and act on their experiences, as when deciding whether an interaction with a firm was satisfying and whether to buy from it? Previous work on the summary of continuous experiences has tended to focus on a handful of experience patterns and...
View Details
Keywords:
Customer Experience;
Customer Journey;
Natural Language Processing;
Summarization;
Customer Satisfaction;
Outcome or Result;
Decision Choices and Conditions
De Freitas, Julian, Ahmet Uğuralp, Zeliha Uğuralp, Pechthida Kim, and Tomer Ullman. "Summarizing the Mental Customer Journey." Harvard Business School Working Paper, No. 23-038, January 2023.
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
How can a successful executive assess her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to find a therapeutic window for Cleave Therapeutics oncology drug was on track but faced an uncertain future. Overseeing the...
View Details
- December 2022
- Technical Note
Technical Note on ESG and Impact Investing in Real Estate
By: Arthur I. Segel, Dwight Angelini, Matt Kelly, Elisha Baker and Miguel Goncalves
- December 2022
- Case
Iberdrola: Leading the Energy Revolution
By: Juan Alcácer and Emer Moloney
At the end of 2019, Ignacio Galán, the Chairman and CEO of the world's third largest utility, Iberdrola, relected on his almost 20 years at the company. He managed a portfolio of three very different businesses, each with their own specific opportunities and...
View Details
Keywords:
Energy;
Energy Generation;
Energy Sources;
Non-Renewable Energy;
Renewable Energy;
Engineering;
Innovation and Management;
Innovation Leadership;
Innovation Strategy;
Technological Innovation;
Leadership;
Growth and Development Strategy;
Market Timing;
Industry Growth;
Mission and Purpose;
Strategy;
Energy Industry;
Green Technology Industry;
Utilities Industry;
Transportation Industry;
Auto Industry;
Spain;
United Kingdom;
United States;
Brazil;
Mexico
- December 13, 2022
- Article
6 Ways Companies Fail to Help Workers Grow
By: Joseph Fuller, Matthew Sigelman and Nik Dawson
The authors recently studied Fortune 250 companies and ranked them based on the lived experience of three million of their U.S. workers. One of their key findings was that even top-ranked firms fail to deliver consistently on worker advancement. To understand why this...
View Details
Keywords:
Personal Development and Career;
Training;
Business Model;
Outcome or Result;
Performance Evaluation;
Opportunities
Fuller, Joseph, Matthew Sigelman, and Nik Dawson. "6 Ways Companies Fail to Help Workers Grow." Harvard Business Review Digital Articles (December 13, 2022).
- December 2022
- Article
Conflicting Interests and the Effect of Fiduciary Duty: Evidence from Variable Annuities
By: Mark Egan, Shan Ge and Johnny Tang
We examine the variable annuity market to study conflicts of interest and the effect of fiduciary duty in brokerage markets. Insurers typically pay brokers higher commissions for selling more expensive annuities. Our results indicate that sales are four times as...
View Details
Keywords:
Variable Annuity;
Brokers;
Fiduciary Duty;
Finance;
Investment;
Insurance;
Conflict of Interests;
Financial Services Industry;
Insurance Industry;
United States
Egan, Mark, Shan Ge, and Johnny Tang. "Conflicting Interests and the Effect of Fiduciary Duty: Evidence from Variable Annuities." Review of Financial Studies 35, no. 12 (December 2022): 5334–5386.
- December 2022 (Revised December 2022)
- Case
Ribbit Capital and the Gauntlet Investment Opportunity
By: Shai Bernstein and Allison M. Ciechanover
Ten-year-old, Palo Alto-based Ribbit Capital is best-known for its global investments in fintech. The firm was also an early advocate of crypto and blockchain, having invested in more than two dozen startups in the space in the past decade. In the Spring of 2022,...
View Details
- 2022
- Working Paper
The Disappearing Index Effect
By: Robin Greenwood and Marco Sammon
The abnormal return associated with a stock being added to the S&P 500 has fallen from an average of 3.4% in the 1980s and 7.6% in the 1990s to 0.8% over the past decade. This has occurred despite a significant increase in the percentage of stock market assets linked...
View Details
Greenwood, Robin, and Marco Sammon. "The Disappearing Index Effect." Harvard Business School Working Paper, No. 23-025, December 2022.
- Winter 2022
- Article
Vaccines and the COVID-19 Pandemic: Lessons from Failure and Success
By: Scott Duke Kominers and Alex Tabarrok
The losses from the global COVID-19 pandemic have been staggering—trillions in economic costs, on top of significant losses of life, health, and well-being. The world made significant and successful investments in vaccines to mitigate the pandemic, yet there were...
View Details
Keywords:
COVID-19;
Vaccination;
Market Design;
Health Pandemics;
Loss;
Outcome or Result;
Opportunities;
Crisis Management
Kominers, Scott Duke, and Alex Tabarrok. "Vaccines and the COVID-19 Pandemic: Lessons from Failure and Success." Oxford Review of Economic Policy 38, no. 4 (Winter 2022): 719–741.
- November 2022
- Background Note
The Role of ESG in Investment Strategy
By: Vikram S Gandhi and Christopher Diak
- November 2022
- Case
Ajax Health: A New Model for Medical Technology Innovation
By: Regina E. Herzlinger and Ben Creo
This case teaches key success factors for both startups and established medtech firms. It examines how to structure a firm to maximize financial returns. Medtech entrepreneur Duke Rohlen is proposing a new model for innovation and business growth. From 2007 to 2019,...
View Details
- November 2022
- Case
The Battle Among Channels for Marketing Pharmaceuticals: UpScript, Pharmacy Benefit Managers, and Direct-to-Consumer Sales
By: Regina E. Herzlinger and Tiffany Farrell
Can an online pharmacy both improve the quality and speed of care for patients who need branded drugs and stabilize profits for pharmaceutical manufacturers? UpScript, after years spent achieving legal and regulatory compliance and simultaneous technological innovation...
View Details
- November 2022
- Case
The Globalization of Manchester City Football Group
By: Maria P. Roche, Tiona Zuzul, Exequiel Hernandez and Amy Klopfenstein
This case describes the efforts of City Football Group (CFG) to purchase Esporte Clube Bahia (Bahia), a Brazilian professional soccer club. CFG’s strategy was to acquire under-performing clubs worldwide, invest money in high-profile players, and improve the teams’...
View Details
Keywords:
Business Ventures;
Acquisition;
Business Conglomerates;
Geography;
Geographic Location;
Geographic Scope;
Globalization;
Global Strategy;
Globalized Markets and Industries;
Markets;
Demand and Consumers;
Marketing;
Brands and Branding;
Organizations;
Organizational Change and Adaptation;
Sports;
Strategy;
Competition;
Competitive Advantage;
Diversification;
Expansion;
Sports Industry;
Europe;
United Kingdom;
England;
South America;
Brazil